Ahead of the House Ways and Means Committee hearing titled “More Cures for More Patients: Overcoming Pharmaceutical Barriers,” ERIC sent a letter to Chairman Doggett and Ranking Member Nunes commending lawmakers’ efforts to lower drug costs by addressing abuses that hinder competition and drive up prescription drug costs for patients.
Topic Archives:
ERIC Fights a Fierce Battle on Surprise Bills in Virginia
ERIC Fights For Strong Telehealth Provisions in Massachusetts and Idaho
House Ways and Means Hearing on Paid Family and Medical Leave
ERIC Thanks House and Senate Leadership for Passing SECURE Act
Today, ERIC signed letters sent to the U.S. House of Representatives and the U.S. Senate leadership thanking them for their work on the SECURE Act.
Victory: ERIC’s Decade-Long Fight to Repeal Cadillac Tax is Successful
ERIC has achieved a major legislative victory, as Congress today finally repealed the ACA’s “Cadillac” excise tax on high-cost employer-sponsored health insurance. For the past decade, ERIC has been fighting against the tax year after year.
ERIC Joins More Than 1,000 Groups Calling for Lawmakers to Repeal Cadillac Tax
ERIC joined more than 1,000 other organizations in calling for the U.S. Senate to fully repeal the Cadillac tax by passing S. 684, the Middle-Class Health Benefits Tax Repeal Act of 2019. The bill currently has 63 cosponsors.
Multiemployer Pension Reform Will Benefit All Plan Sponsors
The ERISA Industry Committee applauds Senators Grassley and Alexander for moving forward to address the crisis in the multiemployer pension system. Since this crisis impacts plan sponsors of all sizes and across the country, it must be addressed comprehensively to ensure the protection of retirement benefits for millions of workers.
Rx Costs Update, NY Surprise Billing Data, Financing Medicare for All, and More!
ERIC Joins Business Groups in Letter to Senate on PCORI
ERIC joined with other business groups in a letter sent to the U.S. Senate today sharing support for, and feedback on, the Patient-Centered Outcomes Research Institute Reauthorization Act discussion draft.